Mount Carmel Health Partners HEDIS Tip Sheets | Page 6

  HEDIS

Tip Sheet   
Annual Monitoring for Patients on Persistent Medications:
Digoxin

Definition: Percentage of members 18 years of age and older who received at least 180 treatment days of
ambulatory medication therapy with digoxin during the measurement period and at least one therapeutic
monitoring event within the measurement period.
Service Needed: At least one serum potassium AND serum creatinine AND a serum digoxin level during the
measurement period. Either a lab panel test (Chem7, Chem14, CMP, and BMP) or serum creatinine and serum
potassium meet the first portion of the guideline.
Exclusions: Hospice care in measurement year.
Chart Review Tips:
• Digoxin can be found in the “Medications” section of the chart or noted in the recent office visit/progress note.
• Serum creatinine and serum potassium levels can be found in the “Lab” section of the chart.
• Serum digoxin levels can be found in the “Lab” section of the chart.
Member Outreach Tips:
• Ask patients if they are taking (or have been prescribed) digoxin and how long they have been taking it before
asking if they have had any lab tests.
• If patients have not had their potassium and creatinine OR digoxin levels checked in the last year, ask them to
schedule an appointment with their PCP to have this scheduled. More than likely, this would be their annual
preventive visit.
Supplemental Data Tips
• There should be little need for supplemental data for this measure because the potassium, creatinine and digoxin
values are not needed to meet the measure; in other words, a simple claim that the tests were done is sufficient.
• The serum creatinine, serum potassium, and serum digoxin tests do not need to be on the same day, only within
the measurement period.
• Digoxin may also be prescribed as digitalis or lanoxin.
6